Publicaciones en colaboración con investigadores/as de University of Florida (17)

2023

  1. Impact of Age at the Time of the First ST-Elevation Myocardial Infarction on 10-Year Outcomes (from the EXAMINATION-EXTEND Trial)

    American Journal of Cardiology, Vol. 190, pp. 32-40

2011

  1. Can resistance to aspirin be reversed after an additional dose?

    Journal of Thrombosis and Thrombolysis, Vol. 32, Núm. 3, pp. 356-361

  2. Impact of insulin receptor substrate-1 genotypes on platelet reactivity and cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease

    Journal of the American College of Cardiology, Vol. 58, Núm. 1, pp. 30-39

  3. Tackling the thrombotic burden in patients with acute coronary syndrome and diabetes mellitus

    Expert Review of Cardiovascular Therapy, Vol. 9, Núm. 6, pp. 697-710

2010

  1. Impact of Chronic Kidney Disease on Platelet Function Profiles in Diabetes Mellitus Patients With Coronary Artery Disease Taking Dual Antiplatelet Therapy

    Journal of the American College of Cardiology, Vol. 55, Núm. 11, pp. 1139-1146

2008

  1. Functional impact of high clopidogrel maintenance dosing in patients undergoing elective percutaneous coronary interventions. Results of a randomized study

    Thrombosis and Haemostasis, Vol. 99, Núm. 1, pp. 161-168

2007

  1. Impact of Platelet Reactivity on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease

    Journal of the American College of Cardiology, Vol. 50, Núm. 16, pp. 1541-1547

  2. Variability in Individual Responsiveness to Clopidogrel. Clinical Implications, Management, and Future Perspectives

    Journal of the American College of Cardiology, Vol. 49, Núm. 14, pp. 1505-1516

2006

  1. Influence of aspirin resistance on platelet function profiles in patients on long-term aspirin and clopidogrel after percutaneous coronary intervention

    American Journal of Cardiology, Vol. 97, Núm. 1, pp. 38-43

  2. Influence of the CD14 C260T Promoter Polymorphism on C-Reactive Protein Levels in Patients With Coronary Artery Disease

    American Journal of Cardiology, Vol. 98, Núm. 9, pp. 1182-1184

  3. Insulin Therapy Is Associated With Platelet Dysfunction in Patients With Type 2 Diabetes Mellitus on Dual Oral Antiplatelet Treatment

    Journal of the American College of Cardiology, Vol. 48, Núm. 2, pp. 298-304

  4. Lack of association between gene sequence variations of platelet membrane receptors and aspirin responsiveness detected by the PFA-100 system in patients with coronary artery disease

    Platelets, Vol. 17, Núm. 8, pp. 586-590

  5. Oral antiplatelet therapy and percutaneous coronary intervention

    Revista Espanola de Cardiologia Suplementos, Vol. 6, Núm. H

2005

  1. Lack of association between the P2Y12 receptor gene polymorphism and platelet response to clopidogrel in patients with coronary artery disease

    Thrombosis Research, Vol. 116, Núm. 6, pp. 491-497

  2. Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment

    Diabetes, Vol. 54, Núm. 8, pp. 2430-2435

  3. Raising the loading dose of clopidogrel: Aiming at the proper target? (multiple letters)

    European Heart Journal

  4. Variability in platelet aggregation following sustained Aspirin and Clopidogrel treatment in patients with coronary heart disease and influence of the 807 C/T polymorphism of the glycoprotein Ia gene

    American Journal of Cardiology, Vol. 96, Núm. 8, pp. 1095-1099